DexCom Inc (BSP:D1EX34)
R$ 9.65 0 (0%) Market Cap: 188.46 Bil Enterprise Value: 189.05 Bil PE Ratio: 47.26 PB Ratio: 15.58 GF Score: 74/100

DexCom Inc at Piper Sandler Healthcare Conference (Virtual) Transcript

Dec 01, 2020 / 08:00PM GMT
Release Date Price: R$8.43 (-0.76%)
Matthew Oliver O;Brien;Steven R. Pacelli
Piper Sandler & Co., Research Division - MD & Senior Research Analyst;DexCom

' -

Okay. Good afternoon, everyone. Thanks for joining us during our annual health care conference, and I hope everything is going well with this virtual format. This is Matt O'Brien from Piper's equity research team. I'll be moderating this fireside chat with the management team from DexCom.

From the company are Steven Pacelli, who is the Executive Vice President of Strategy and Corporate Development; Jereme Sylvain, who's the Senior Vice President of Finance and the Chief Accounting Officer; as well as Sean Christensen, Director of Corporate Affairs.

One quick housekeeping item. If you have questions for anyone on the panel, there is a box down at the bottom, where you can ask your questions or send them directly to me. I'm happy to ask them on your behalf. That's [email protected].

So with that out of the way here, let's go ahead and get started with the fireside. Guys, thanks so much for joining us.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot